Award-winning WorkSafe initiative ensures blood culture safety as the first line of defense against Healthcare-Associated Infections
bioMérieux - First Quarter 2008 Business Review
Sales up 6.2% like-for-like.
bioMérieux Bestowed 2007 Frost & Sullivan European Healthcare-Associated Infection Control Technology Leadership Award
frost_thumb181.jpg The 2007 European Healthcare-Associated Infection Control Technology Leadership Award is conferred upon bioMérieux in recognition of its unparalleled leadership and commitment toward healthcare-associated infection control and its pioneering and extensive work in this field.
University of Sunderland and bioMérieux Collaborate in New Research Significantly Improving the Identification of Pseudomonas Aeruginosa, a Major Cause of Death in Cystic Fibrosis Patients
A team of researchers from the University of Sunderland and bioMérieux, a leading company in the field of in vitro diagnostics, have achieved a new step in the fight against Pseudomonas aeruginosa, a bacterium responsible for deadly healthcare-associated infections, which kills tens of thousands of people throughout the world every year .1
bioMérieux and Hitachi High-Technologies Corporation Enter into Long-Term Strategic Partnership
Focus on microbiology and molecular diagnostics
2007 Financial Results
2007: Clear improvement in growth and in operating margin before non-recurring items
FDA Clears bioMérieux's VIDAS® NT-proBNP, a High Medical Value Test for Diagnosis of Heart Failure
bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration to market VIDAS® NT-proBNP, a test that helps the diagnosis of heart failure.
bioMérieux's Food Safety Handbook is Now Available
food_safety_petit_thumb61.jpg bioMérieux, a world leader in industrial microbiology control, announces that the first Food Safety Handbook: Microbiological Challenges is now available for food professionals. Published by bioMérieux Editions, the handbook was developed with contributions from 24 internationally renowned experts.
bioMérieux and Wescor Bring a New Gram Staining Instrument for Enhanced Microbiology Laboratory Workflow
bioMérieux (Euronext: BIM) and Wescor, an ELITech Group Company have signed an agreement by which bioMérieux will become Wescor’s exclusive worldwide partner for marketing two customized slide stainer instruments for Gram and tuberculosis bacillus under the bioMérieux brand.
bioMérieux and Shanghai Kehua Bio-Engineering Build Joint Venture
Shanghai Kehua Bio-engineering (Stock Code: 002022) and bioMérieux (Euronext: BIM) announce the creation of a Shanghai-based joint venture to which bioMérieux will transfer microplate immunoassay manufacturing currently located at its Boxtel site in the Netherlands.